GlassScriptPhysician profile
Steven Rosenblatt
NPI 1134142201
$3,284.97
in general payments reported to CMS, 2019-2025
20 companies · $148 in 2025
The $148 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $116 · 2021: $292 · 2022: $186 · 2023: $407 · 2024: $2,000 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,554.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $1,935.64 | 2024 | M22 |
| Amgen INC. | $235.37 | 2019-2023 | Otezla, Repatha |
| Merz North America, INC. | $227.50 | 2023 | Xeomin |
| Otsuka America Pharmaceutical, INC. | $92.39 | 2021-2023 | Rexulti |
| Merck Sharp & Dohme LLC | $89.73 | 2020-2021 | |
| Abbvie INC. | $89.66 | 2022-2025 | |
| Lundbeck LLC | $86.88 | 2025 | Vyepti |
| Astrazeneca Pharmaceuticals LP | $79.97 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $76.75 | 2019-2021 | |
| Gilead Sciences, INC. | $55.46 | 2021 | |
| Galderma Laboratories, L.P. | $49.57 | 2020-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $48.65 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $42.28 | 2019 | |
| Exact Sciences Corporation | $33.30 | 2024 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $31.70 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $29.35 | 2023 | |
| Hikma Pharmaceuticals USA | $21.80 | 2019 | |
| Alkermes, INC. | $21.35 | 2021 | |
| Sanofi-Aventis U.S. LLC | $20.39 | 2020 | |
| Bausch Health US, LLC | $17.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Rosenblatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.